cysteamine has been researched along with folic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Diller, A; Schirch, LV | 1 |
| Choi, YW; Kang, MH; Kang, MJ; Park, MJ; Park, SH | 1 |
| Biparva, P; Hatami, M; Karimi-Maleh, H | 1 |
| Choi, YW; Kang, MH; Kang, MJ; Kim, SR; Kwon, YH; Lee, SG; Yeom, DW; Yoo, HJ; Yoon, HY | 1 |
| Golshan, M; Mirshekarpour, M; Mohammadi, M; Roghani-Mamaqani, H; Salami-Kalajahi, M | 1 |
| Attaran, N; Ay, MR; Ghadiri, H; Khademi, S; Kharrazi, S; Sarkar, S; Shakeri-Zadeh, A | 1 |
| Hasanzadeh, M; Jouyban, A; Soleymani, J; Somi, MH | 1 |
1 review(s) available for cysteamine and folic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for cysteamine and folic acid
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Serine transhydroxymethylase. Affinity of the active site for substrates, substrate analogues, and anions.
Topics: Alanine; Aldehydes; Aminoisobutyric Acids; Animals; Benzoates; Binding Sites; Chlorides; Cysteamine; Cysteine; Electrophoresis; Folic Acid; Glycine; Hot Temperature; Hydrogen-Ion Concentration; Kinetics; Mercaptoethanol; Models, Biological; Organophosphonates; Phosphates; Potassium; Propionates; Pyridoxal Phosphate; Rabbits; Serine; Spectrophotometry; Stereoisomerism; Sulfates; Sulfhydryl Compounds; Sulfonic Acids; Thermodynamics; Threonine; Transferases; Ultracentrifugation | 1971 |
Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.
Topics: Amino Acid Sequence; Cell Line, Transformed; Cell Survival; Cysteamine; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Folic Acid; HeLa Cells; Humans; Intracellular Space; Keratinocytes; Liposomes; Microscopy, Fluorescence; Molecular Sequence Data; Nanoparticles; Peptides; Protein Conformation | 2013 |
A novel modified carbon paste electrode based on NiO/CNTs nanocomposite and (9, 10-dihydro-9, 10-ethanoanthracene-11, 12-dicarboximido)-4-ethylbenzene-1, 2-diol as a mediator for simultaneous determination of cysteamine, nicotinamide adenine dinucleotide
Topics: Benzene Derivatives; Biosensing Techniques; Carbon; Cysteamine; Electrochemical Techniques; Electrodes; Folic Acid; Humans; Limit of Detection; NAD; Nanocomposites; Nanotubes, Carbon; Nickel; Pharmaceutical Preparations | 2013 |
Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery.
Topics: Cell Line, Tumor; Cell-Penetrating Peptides; Cysteamine; Drug Carriers; Drug Delivery Systems; Folic Acid; HeLa Cells; Humans; Ligands; Liposomes; Nanoparticles; Peptides | 2015 |
Synthesis and characterization of poly(propylene imine)-dendrimer-grafted gold nanoparticles as nanocarriers of doxorubicin.
Topics: Antibiotics, Antineoplastic; Chlorides; Citrates; Cysteamine; Dendrimers; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; Folic Acid; Gold; Gold Compounds; Hydrogen-Ion Concentration; Kinetics; Metal Nanoparticles; Polypropylenes; Solubility | 2017 |
Folic acid-cysteamine modified gold nanoparticle as a nanoprobe for targeted computed tomography imaging of cancer cells.
Topics: Biocompatible Materials; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Contrast Media; Cysteamine; Folic Acid; Gold; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Neoplasms; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Tomography, X-Ray Computed | 2018 |
Differentiation and targeting of HT 29 cancer cells based on folate bioreceptor using cysteamine functionalized gold nano-leaf.
Topics: Biosensing Techniques; Cell Survival; Cysteamine; Doxorubicin; Dynamic Light Scattering; Electrochemical Techniques; Electrodes; Folate Receptors, GPI-Anchored; Folic Acid; Gold; HEK293 Cells; HT29 Cells; Humans; Limit of Detection; Metal Nanoparticles; Microscopy, Fluorescence; Molecular Imaging; Molecular Probes; Reproducibility of Results | 2020 |